However, in other contexts, such as retinal inflammation, tumor microenvironments, or aging, excessive Cldn5 expression may contribute to pathology by excessively tightening barriers, limiting immune surveillance, or altering endothelial plasticity. The gene discussed is CLDN5; the disease is neoplasm.